FAST NEWS: LianBio Shares Sag in First U.S. IPO By a Chinese Company After Pause
The latest: Shares of biotech startup LianBio (LIAN.US) sagged in their trading debut on the Nasdaq, as the company became the first new listing by a Chinese firm in New…
Xiaobai Maimai Eyes Cancer Treatment as E-Commerce Pivot Sputters
Former P2P lender’s stock soared up to tenfold after announcement of latest shift, but later gave up much of the gains Key Takeaways: Xiaobai Maimai, the former P2P lender known…
RELATED ARTICLES
-
With no cure in sight, drugs firm LianBio begins exit strategy
LIAN.US - Is shunned Shein the future for blockbuster China IPOs?
- CHINA BULLETIN: Services, Trade Send Positive Signals
-
Hong Kong’s lukewarm IPO market may be about to heat up
0388.HK
-
ZKH Group IPO falls flat as investors worry over slowing growth
ZKH.US
-
ArriVent wows investors with promising China-developed lung cancer treatment
AVBP.US
- CHINA BULLETIN: Blinken, Yellen Talk Up China Challenge
